1994
DOI: 10.1006/geno.1994.1331
|View full text |Cite
|
Sign up to set email alerts
|

Murine Chromosomal Location of the μ and κ Opioid Receptor Genes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
23
0
1

Year Published

1997
1997
2019
2019

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 53 publications
(25 citation statements)
references
References 0 publications
1
23
0
1
Order By: Relevance
“…This QTL for oral morphine preference, termed Mop2, was confirmed in a follow-up study (Alexander et al, 1996) and support was generated for the concept that it had a broader influence with regard to the pharmacological effects of morphine being involved also in determining morphine-induced analgesia and the density of [ 3 H]naloxone binding sites in the brain (Belknap et al, 1995). Subsequent mapping of the Mu opioid receptor gene (Oprm) to the same chromosomal location as the Mop2 QTL (Kozak et al, 1994;Giros et al, 1995) focused attention on this gene as a strong candidate for mediating differences in opioid-related effects between B6 and D2 mice. In spite of intensive study, the causative genetic variation that underlies Mop2 has yet to be identified.…”
Section: Discussionmentioning
confidence: 84%
See 1 more Smart Citation
“…This QTL for oral morphine preference, termed Mop2, was confirmed in a follow-up study (Alexander et al, 1996) and support was generated for the concept that it had a broader influence with regard to the pharmacological effects of morphine being involved also in determining morphine-induced analgesia and the density of [ 3 H]naloxone binding sites in the brain (Belknap et al, 1995). Subsequent mapping of the Mu opioid receptor gene (Oprm) to the same chromosomal location as the Mop2 QTL (Kozak et al, 1994;Giros et al, 1995) focused attention on this gene as a strong candidate for mediating differences in opioid-related effects between B6 and D2 mice. In spite of intensive study, the causative genetic variation that underlies Mop2 has yet to be identified.…”
Section: Discussionmentioning
confidence: 84%
“…Quantitative trait locus (QTL) mapping studies indicate that a locus on the proximal end of chromosome 10 called Mop2 harbors a gene(s) that determines a large part of the difference in voluntary oral morphine consumption between B6 and DBA/2 (D2) mice (Berrettini et al, 1994b). The gene encoding the Mu opioid receptor (Oprm) is located on proximal chromosome 10 (Kozak et al, 1994;Giros et al, 1995) and is a compelling candidate for the Mop2 QTL; however, the causative genetic variation between B6 and D2 mice has yet to be determined.…”
Section: Introductionmentioning
confidence: 99%
“…The MOR gene (Oprm1) spans approximately 250 kb of proximal Chr. 10 (Kozak et al, 1994;Giros et al, 1995) and contains at least 19 alternatively spliced exons (Doyle et al, 2007a, b) that encode a number of MOR isoforms capable of binding morphine, other opiates, and endogenous opioid peptides (Pan et al, , 2000(Pan et al, , 2001Bolan et al, 2004). There is ample pharmacological evidence that MORs represent the major sites of interaction of clinically used opioid analgesics, particularly morphine (Pasternak, 2001a).…”
Section: Discussionmentioning
confidence: 99%
“…Studies of quantitative trait loci in mice identified a chromosomal region containing the opioid receptor gene as contributing to a substantial amount of the variance in analgesic and reward responses to morphine (Belknap and Crabbe, 1992;Berrettini et al, 1994;Kozak et al, 1994;Belknap et al, 1995;Crabbe et al, 1999). Also, studies of mice with targeted deletion of the opioid receptor gene definitively established this receptor as essential for morphine analgesia, physical dependence, and reward as measured by antinociception, withdrawal, conditioned place preference, and self-administration studies (Matthes et al, 1996;Sora et al, 1997;Kitanaka et al, 1998;Loh et al, 1998;Becker et al, 2000).…”
Section: Selected Identified Genesmentioning
confidence: 99%